Walleye Capital’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Sell |
37,907
-31,253
| -45% | -$1.53M | 0.01% | 652 |
|
|
2025
Q1 | $3.52M | Sell |
69,160
-40,844
| -37% | -$2.08M | 0.02% | 447 |
|
|
2024
Q4 | $4.97M | Buy |
+110,004
| New | +$4.97M | 0.01% | 434 |
|
|
2024
Q3 | – | Sell |
-85,147
| Closed | -$2.6M | – | 2785 |
|
|
2024
Q2 | $2.6M | Buy |
85,147
+73,484
| +630% | +$2.25M | ﹤0.01% | 703 |
|
|
2024
Q1 | $339K | Buy |
+11,663
| New | +$339K | ﹤0.01% | 1581 |
|
|
2023
Q4 | – | Sell |
-72,030
| Closed | -$1.61M | – | 2822 |
|
|
2023
Q3 | $1.61M | Buy |
72,030
+65,226
| +959% | +$1.46M | ﹤0.01% | 724 |
|
|
2023
Q2 | $277K | Sell |
6,804
-76,942
| -92% | -$3.13M | ﹤0.01% | 1207 |
|
|
2023
Q1 | $4.06M | Sell |
83,746
-11,485
| -12% | -$556K | 0.06% | 340 |
|
|
2022
Q4 | $3.63M | Buy |
+95,231
| New | +$3.63M | 0.07% | 323 |
|
|
2022
Q3 | – | Sell |
-60,412
| Closed | -$2.42M | – | 2647 |
|
|
2022
Q2 | $2.42M | Buy |
60,412
+50,379
| +502% | +$2.02M | 0.07% | 303 |
|
|
2022
Q1 | $374K | Buy |
+10,033
| New | +$374K | 0.01% | 1135 |
|
|
2020
Q1 | – | Sell |
-1,500
| Closed | -$72K | – | 856 |
|
|
2019
Q4 | $72K | Buy |
+1,500
| New | +$72K | ﹤0.01% | 504 |
|
|
2019
Q3 | – | Sell |
-1,294
| Closed | -$58K | – | 883 |
|
|
2019
Q2 | $58K | Buy |
+1,294
| New | +$58K | 0.01% | 309 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 556 |
|